Dan G. Duda, DMD, Ph.D., of the Edwin L. Steele Laboratories for Tumor Biology and Department of Radiation Oncology at Massachusetts General Hospital, is the corresponding author of a paper published ...

Bristol Myers Squibb has won FDA approval for an injectable version of its blockbuster cancer immunotherapy Opdivo, a regulatory decision that gives patients a more convenient dosing option and ...

The market is projected to expand from $70.8 billion in 2024 to $125.5 billion by 2030 as precision medicine, CAR-T therapies, bispecific antibodies and targeted treatments reshape hematologic cancer ...

Immunotherapy is a type of cancer treatment that stimulates a patient's immune system to attack tumors. While promising, its effectiveness varies among patients. The new VUB technology helps identify ...

Cancer immunotherapy has revolutionized treatment for patients, whereby the body's own immune system is harnessed to destroy cancer cells. Typically, several molecules restrain the ability of T cells ...

Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community. You ...

While advances in immunotherapy have already had a transformative impact on cancer care, outdated clinical trial metrics have kept this important technology out of reach for large swaths of the ...

Which patients with early-stage breast cancer will benefit most from immunotherapy, and at what point is immunotherapy most useful? This question spans neoadjuvant and adjuvant settings. In the ...

An AI system built by the Allen Institute for AI has found evidence that a common form of breast cancer may respond to ...

At the beginning of 2024, the American Cancer Society predicted that 2,001,140 new cancer cases and 611,720 cancer deaths would occur in the United States. Now, as the year draws to a close, experts ...